Navigation Links
Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L.P. to Commercialize Intermezzo(R) in the United States
Date:8/2/2009

PT. RICHMOND, Calif., Aug. 2 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) will host a conference call to discuss its exclusive license and collaboration agreement with Purdue Pharmaceutical Products L.P. to commercialize Intermezzo((R)) (zolpidem tartrate sublingual tablet) in the United States. The FDA has established October 30, 2009 as the Prescription Drug User Fee Act (PDUFA) action date for the Intermezzo((R)) New Drug Application (NDA).

Conference Call Information

          Date: Monday, August 3, 2009
          Time: 8:30 a.m. ET
          Dial-in (U.S.): 877-545-1490
          Dial-in (International): 719-325-4864

A simultaneous web cast of the conference call will be available on the Investor Relations section of the Transcept website at www.transcept.com. A replay of the call will be available on the website shortly after the conclusion of the call until Monday, September 7, 2009.

A telephone replay of the conference call will be available beginning August 3, 2009 at 11:30 a.m. ET and ending on August 17, 2009. The replay telephone number is 888-203-1112 (U.S.) or 719-457-0820 (International), Replay Passcode: 5541799.

About Transcept

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. For further information, please visit the company's website at: www.transcept.com.

    Contacts:          Transcept Pharmaceuticals, Inc.
                       Greg Mann
                       Director of Corporate Communications
                       (510) 215-3567
                       gmann@transcept.com

                       The Ruth Group
                       Investors / Media
                       Sara Ephraim Pellegrino / Jason Rando
                       (646) 536-7017 / 7025
                       spellegrino@theruthgroup.com
                       jrando@theruthgroup.com


'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
2. Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R)
3. Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009
4. Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association
5. Transcept Pharmaceuticals Reports First Quarter 2009 Financial Results
6. Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
7. Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results
8. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
9. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
10. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
11. Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... 2017 , ... Marathon running has surged in popularity in ... running increases exposure to ultraviolet radiation, a carcinogen that promotes skin cancer. Studies ... half may be adequately protecting themselves with proper clothing and sunscreen. , ...
(Date:8/21/2017)... ... 21, 2017 , ... PIXACORE , an independent full-service agency with a ... agencies of the year by MM&M. , This is the first time PIXACORE has ... for the agency. PIXACORE’s newfound recognition reflects its steady trajectory of growth and ...
(Date:8/21/2017)... ... August 21, 2017 , ... ... UnitedHealth Group (NYSE: UNH), has made a multi-million dollar partnership commitment to ... stress disorder (PTSD) and traumatic brain injuries (TBI) over the next year. ...
(Date:8/20/2017)... ... August 20, 2017 , ... HIPAA ... Management System has assisted multiple clients in successfully passing audits such as ... Control Level 2 (AICPA SOC Level 2), and State Data Use Agreement Audits. ...
(Date:8/19/2017)... (PRWEB) , ... August 19, 2017 , ... ... Ed Begley, Jr., will feature the Aurum Group in an upcoming episode, slated ... This segment of Innovations will feature the Aurum Group; a company committed to ...
Breaking Medicine News(10 mins):
(Date:8/10/2017)... 2017  Physical Rehabilitation Network (PRN), acquired the long-standing outpatient ... Colorado . The reputable clinic will continue to be ... with his staff of four clinicians. Lipkin received his doctorate ... over 10 years of experience with a strong background in ... marks the 10th PRN clinic in and around the ...
(Date:8/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... Board of Directors has approved the payment of a quarterly ... The cash dividend of ... 27, 2017 to stockholders of record as of the close ... are subject to approval of the Board of Directors and ...
(Date:8/4/2017)... The search for test results that can ... has long been the goal of healthcare providers and ... the largest meeting of lab professionals and IVD firms ... firm Kalorama Information.  The firm said scores of companies ... supplies and software were at the American Association for ...
Breaking Medicine Technology: